These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24105048)

  • 1. Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z
    Clin Transl Oncol; 2014 Jun; 16(6):567-72. PubMed ID: 24105048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
    Tang Y; Khan MA; Goloubeva O; Lee DI; Jelovac D; Brodie AM; Hussain A
    Clin Cancer Res; 2006 Jan; 12(1):169-74. PubMed ID: 16397039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
    Shigemura K; Arbiser JL; Sun SY; Zayzafoon M; Johnstone PA; Fujisawa M; Gotoh A; Weksler B; Zhau HE; Chung LW
    Cancer; 2007 Apr; 109(7):1279-89. PubMed ID: 17326044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
    Wu H; Xin Y; Xiao Y; Zhao J
    Cancer Biother Radiopharm; 2012 Apr; 27(3):204-9. PubMed ID: 22283637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
    Muramaki M; Miyake H; Hara I; Kamidono S
    Int J Oncol; 2005 Mar; 26(3):623-8. PubMed ID: 15703816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.
    Cumashi A; Tinari N; Rossi C; Lattanzio R; Natoli C; Piantelli M; Iacobelli S
    Cancer Lett; 2008 Nov; 270(2):229-33. PubMed ID: 18586384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
    Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.
    Liu G; Taylor SA; Marrinan CH; Hsieh Y; Bishop WR; Kirschmeier P; Long BJ
    Int J Cancer; 2009 Dec; 125(11):2711-20. PubMed ID: 19530253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer.
    Luo Q; Li Z; Yan J; Zhu F; Xu RJ; Cai YZ
    J Med Food; 2009 Aug; 12(4):695-703. PubMed ID: 19735167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases.
    Zhao P; Luo R; Wu J; Xie F; Li H; Xiao X; Fu L; Zhu X; Liu R; Zhu Y; Liang Z; Huang W
    J Cell Mol Med; 2010 Jan; 14(1-2):381-91. PubMed ID: 26065034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
    Tang N; Zhang Q; Fang S; Han X; Wang Z
    Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab plus 5-fluorouracil induce growth suppression in the CWR-22 and CWR-22R prostate cancer xenografts.
    Hung H
    Mol Cancer Ther; 2007 Aug; 6(8):2149-57. PubMed ID: 17699714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model.
    Galaup A; Opolon P; Bouquet C; Li H; Opolon D; Bissery MC; Tursz T; Perricaudet M; Griscelli F
    Mol Ther; 2003 Jun; 7(6):731-40. PubMed ID: 12788646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
    Fox WD; Higgins B; Maiese KM; Drobnjak M; Cordon-Cardo C; Scher HI; Agus DB
    Clin Cancer Res; 2002 Oct; 8(10):3226-31. PubMed ID: 12374693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy.
    Sundaram S; Durairaj C; Kadam R; Kompella UB
    Mol Cancer Ther; 2009 Jun; 8(6):1655-65. PubMed ID: 19509261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation.
    Kraus LA; Samuel SK; Schmid SM; Dykes DJ; Waud WR; Bissery MC
    Invest New Drugs; 2003 Aug; 21(3):259-68. PubMed ID: 14578676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.